850EGP
- Active ingredient
- umeclidinium+vilanterol
- Strength
- 62.5/25mcg
- Form
- piece
- Manufacturer
- glaxo smithkline > modern pharma
- Route
- unknown
Uses
Used for maintenance treatment of chronic obstructive pulmonary disease (COPD).
Do not use if
Contraindicated in severe hypersensitivity to the ingredients.
Side effects
Nasopharyngitis, cough, headache, and dry mouth may occur.
Warnings
Not intended for acute bronchospasm or asthma without appropriate therapy.
How it works
Combines a long-acting muscarinic antagonist with a long-acting beta2 agonist for bronchodilation.
Storage
Store in the original package away from moisture.
